Clinical Trial Update: A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 [Phase 1]

View source ↗

Summary

A Phase I 'window of opportunity' study of UGN-201 in bladder cancer patients undergoing radical cystectomy is being conducted, with the trial status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• UGN-201

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer, Bladder | Phase 1 | Status: ACTIVE_NOT_RECRUITING